Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
LIPID NANOPARTICLE COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2021/204175
Kind Code:
A1
Abstract:
Provided herein are lipids that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination.

Inventors:
YING BO (CN)
Application Number:
PCT/CN2021/085879
Publication Date:
October 14, 2021
Filing Date:
April 08, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUZHOU ABOGEN BIOSCIENCES CO LTD (CN)
International Classes:
C07C229/16; A61K9/127; A61K48/00; C07C229/24; C07C233/36; C07C237/12; C07C271/20; C07C275/14; C07D205/04; C07D207/12; C07D211/46; C07D211/58; C07D305/08; C07D307/22; C07D309/14; C07D335/02
Domestic Patent References:
WO2014028487A12014-02-20
WO2020061367A12020-03-26
WO2016210190A12016-12-29
WO2020039631A12020-02-27
WO2012067378A22012-05-24
WO2015199952A12015-12-30
WO2016176330A12016-11-03
WO2015011633A12015-01-29
WO2017112865A12017-06-29
WO2008127688A12008-10-23
WO2008016473A22008-02-07
WO2011015347A12011-02-10
WO2007025008A22007-03-01
WO2001055369A12001-08-02
WO2009075886A12009-06-18
WO2012009644A22012-01-19
WO1999024595A11999-05-20
WO2001055371A12001-08-02
WO2013103659A12013-07-11
WO2012019780A12012-02-16
WO2015002667A12015-01-08
WO2013120497A12013-08-22
WO2013120629A12013-08-22
WO2013120500A12013-08-22
WO2013120627A12013-08-22
WO2013120498A12013-08-22
WO2013120626A12013-08-22
WO2013120499A12013-08-22
WO2013120628A12013-08-22
WO2013120197A12013-08-22
WO2002098443A22002-12-12
WO2003051401A22003-06-26
WO2008052770A22008-05-08
WO2009127230A12009-10-22
WO2006122828A22006-11-23
WO2008083949A22008-07-17
WO2010088927A12010-08-12
WO2010037539A12010-04-08
WO2004004743A12004-01-15
WO2005016376A12005-02-24
WO2006024518A12006-03-09
WO2007095976A22007-08-30
WO2008014979A22008-02-07
WO2008077592A12008-07-03
WO2009030481A12009-03-12
WO2009095226A22009-08-06
WO2011069586A12011-06-16
WO2011026641A12011-03-10
WO2011144358A12011-11-24
WO2012013326A12012-02-02
WO2012089338A12012-07-05
WO2012113513A12012-08-30
WO2012116811A12012-09-07
WO2012116810A12012-09-07
WO2013113502A12013-08-08
WO2013113501A12013-08-08
WO2013113736A12013-08-08
WO2013143698A12013-10-03
WO2013143699A12013-10-03
WO2013143700A22013-10-03
WO2013174409A12013-11-28
WO2014127917A12014-08-28
WO2015024669A12015-02-26
WO2015024668A22015-02-26
WO2015024667A12015-02-26
WO2015024665A12015-02-26
WO2015024666A12015-02-26
WO2015024664A12015-02-26
WO2015101415A12015-07-09
WO2015101414A22015-07-09
WO2015062738A12015-05-07
WO2015101416A12015-07-09
Foreign References:
JPH05331118A1993-12-14
DE19637043A11998-03-19
CN202010275664A2020-04-09
US63011140A
CN202110299761A2021-03-19
US8519110B22013-08-27
US7468275B22008-12-23
US20070048776A12007-03-01
US20110124100A12011-05-26
US6310197B12001-10-30
US6849405B22005-02-01
US7456273B22008-11-25
US7183395B22007-02-27
US20090226470A12009-09-10
US20130177581A12013-07-11
US20090093049A12009-04-09
EP2610341A12013-07-03
EP2610340A12013-07-03
Other References:
SAMBROOK, MOLECULAR CLONING: A LABORATORY MANUAL, 2001
CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, 2003
BUNDGARD, H.: "Design of Prodrugs", 1985, ELSEVIER, pages: 7 - 9,21-24
HIGUCHI, T. ET AL., A.C.S. SYMPOSIUM SERIES, vol. 14
"Bioreversible Carriers in Drug Design", 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS
WELLENSIEK ET AL.: "Genome-wide profiling of human cap-independent translation-enhancing elements", NATURE METHODS, vol. 10, no. 8, August 2013 (2013-08-01), pages 747 - 750, XP055658496, DOI: 10.1038/nmeth.2522
CHAPPELL ET AL., PNAS, vol. 101, no. 26, 29 June 2004 (2004-06-29), pages 9590 - 9594
PANEK ET AL., NUCLEIC ACIDS RESEARCH, vol. 41, 1 September 2013 (2013-09-01), pages 7625 - 7634
ANTIBODY ENGINEERING, 1995
KUBY, IMMUNOLOGY, 1997
HARLOWLANE, ANTIBODIES: A LABORATORY MANUAL, 1989
MOL. BIOLOGY AND BIOTECHNOLOGY: A COMPREHENSIVE DESK REFERENCE, 1995
HUSTON ET AL., CELL BIOPHYSICS, vol. 22, 1993, pages 189 - 224
PLUCKTHUNSKERRA, METH. ENZYMOL., vol. 178, 1989, pages 497 - 515
DAY, ADVANCED IMMUNOCHEMISTRY, 1990
PHYSICIAN'S DESK REFERENCE, 2014
SABNIS ET AL.: "A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates", MOLECULAR THERAPY, vol. 26, no. 6, 2018, XP055644778, DOI: 10.1016/j.ymthe.2018.03.010
KORE ET AL., BIOORGANIC & MEDICINAL CHEMISTRY, vol. 21, 2013, pages 4570 - 4574
CHAPPELL ET AL., PROC. NAT!. ACAD. SET USA, vol. 101, 2004, pages 9590 - 9594
ZHOTT ET AL., PROC. NATL. ACAD. SCI., vol. 102, 2005, pages 6273 - 6278
NAT CELL BIOI, vol. 12, no. 10, October 2010 (2010-10-01), pages 1014 - 20
A. R. GENNAROLIPPINCOTT: "Remington's The Science and Practice of Pharmacy", 2006, WILLIAMS & WILKINS
Attorney, Agent or Firm:
AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: INJECTOR HEAD

Next Patent: SERVICE DATA PREDICTION METHOD AND APPARATUS, ELECTRONIC DEVICE, AND COMPUTER READABLE STORAGE MEDIU...